Analysis of the NIH workshop monoclonal antibodies to human melanoma antigens
- PMID: 6208142
- DOI: 10.1089/hyb.1.1982.1.473
Analysis of the NIH workshop monoclonal antibodies to human melanoma antigens
Abstract
Reagents exchanged at the 2nd workshop on monoclonal antibodies (MoAb) to human melanoma antigens were analyzed using both serological and immunochemical assays. The analysis by laboratories participating in the workshop of our MoAb 225.28S, 345.134S, 376.96S, 465.12S, and 763.24TS reaffirms our own analysis of these reagents in that (1) they all react with the majority of melanoma cell lines tested and (2) the reactivity of MoAb 225.28S and 763.24TS is much more restricted than that of MoAb 345.134S 376.96S, and 465.12S. Our serological analysis revealed that the majority of workshop reagents reacted with cultured melanoma cells. Immunochemical analysis of these monoclonal antibodies allowed for their division into three groups according to the molecular weights of the antigens recognized in immunoprecipitation experiments, greater than 100 kd, 80-100 kd, and DR antigens. Further analysis of the first two groups of monoclonal antibodies by immunodepletion and antibody binding inhibition assays revealed that MoAb 9.2.27, 225.28S, and 763.24TS recognize distinct determinants with a heterogeneous distribution on subpopulations of a high molecular weight melanoma associated antigen. MoAb 376.96S and 705.F6 recognize either the same or spatially close determinant(s).
Similar articles
-
Serological and biochemical analyses of monoclonal antibodies to human melanoma-associated antigens.Hybridoma. 1982;1(4):423-32. doi: 10.1089/hyb.1.1982.1.423. Hybridoma. 1982. PMID: 6208137
-
Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.Hybridoma. 1982;1(4):433-45. doi: 10.1089/hyb.1.1982.1.433. Hybridoma. 1982. PMID: 6208138
-
Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells.Cancer Res. 1987 Sep 15;47(18):4835-41. Cancer Res. 1987. PMID: 3476198
-
Immunochemical characterization of human tumor antigens.Semin Oncol. 1986 Jun;13(2):153-64. Semin Oncol. 1986. PMID: 2424087 Review. No abstract available.
-
Human melanoma-associated antigens identified with monoclonal antibodies.Ric Clin Lab. 1982 Oct-Dec;12(4):517-38. doi: 10.1007/BF02909339. Ric Clin Lab. 1982. PMID: 6760354 Review.
Cited by
-
Characterization and mechanistic studies of a novel melanoma-targeting construct containing IκBa for specific inhibition of nuclear factor-κB activity.Neoplasia. 2010 Oct;12(10):766-77. doi: 10.1593/neo.10214. Neoplasia. 2010. PMID: 20927315 Free PMC article.
-
Unexpected expression of the 250 kD melanoma-associated antigen in human sarcoma cells.Br J Cancer. 1986 Jun;53(6):839-41. doi: 10.1038/bjc.1986.142. Br J Cancer. 1986. PMID: 3718838 Free PMC article. No abstract available.
-
The antimelanoma immunocytokine scFvMEL/TNF shows reduced toxicity and potent antitumor activity against human tumor xenografts.Neoplasia. 2006 May;8(5):384-93. doi: 10.1593/neo.06121. Neoplasia. 2006. PMID: 16790087 Free PMC article.
-
CSPG4 Is a Potential Therapeutic Target in Anaplastic Thyroid Cancer.Thyroid. 2021 Oct;31(10):1481-1493. doi: 10.1089/thy.2021.0067. Epub 2021 Jul 5. Thyroid. 2021. PMID: 34078123 Free PMC article.
-
Targeted apoptosis activation with GrB/scFvMEL modulates melanoma growth, metastatic spread, chemosensitivity, and radiosensitivity.Neoplasia. 2006 Feb;8(2):125-35. doi: 10.1593/neo.05556. Neoplasia. 2006. PMID: 16611405 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical